J.P. Bercu
Advertisement
J.P. Bercu is senior director in nonclinical safety and pathobiology, Gilead Sciences.
Articles by J.P. Bercu
Advertisement
Latest Updated Articles
Managing the Risk of Nitrosamine ImpuritiesMarch 15th 2021
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
2
ADCs, Degraders, Agonists: 4 Deals CMC Teams Should Track
3
Meeting Tomorrow's Market Requirements: Vetter's Perspective on the Future of Fill & Finish
4
Why Drug Shortages Average 5+ Years: PharmTech Explained
5